ALCON INC

Listed Company
ALCCIK 0001167379NYSELarge AcceleratedOphthalmic GoodsV8CHFY ends Dec 31
Period
FY 2025
Revenue
Net Income
$980.00M
Total Assets
$31.55B
Equity
Shares Out
487.43M
Op. Cash Flow

Business

Alcon Inc. researches, develops, manufactures, distributes and sells eye care products, focusing on ophthalmic surgical devices and vision care. Its main products and services include intraocular lenses and other implantables, surgical consumables and equipment, refractive and vitreoretinal systems, contact lenses, ocular health products and ophthalmic pharmaceuticals, together with clinical training, technical support and diagnostics. The company operates through two principal business segments—Surgical and Vision Care—and supports research, development and strategic business development activities. Alcon serves global markets through hospitals, ambulatory surgical centers, eye care professionals, optical retailers, pharmacies, distributors and direct-to-consumer channels.

Summary from filing dated 2026-02-24

Financials

Latest annual snapshot (FY2025, period end 2025-12-31). Full statement history unavailable for this entity.

Revenue
Net income$980.00M
Total assets$31.55B
Total liabilities$9.52B
Stockholders' equity
Operating cash flow

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro